AZoLifeSciences on MSN

Syntax Bio develops CRISPR technology to program stem cell gene activity

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...
News-Medical.Net

CRISPR-based Cellgorithm technology ushers in a new era of cell programming

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced the publication of ...

Programmable CRISPR platform can reduce stem cell differentiation from months to weeks

Syntax Bio, a synthetic biology company programming the next generation of cell therapies, has published new research in ...